Oral gefapixant reduces frequency of refractory or unexplained chronic coughs
1. Gefapixant 45 mg twice a day showed significant reductions in chronic cough over 12-24 weeks compared to placebo. 2. ...
1. Gefapixant 45 mg twice a day showed significant reductions in chronic cough over 12-24 weeks compared to placebo. 2. ...
Gastroesophageal reflux disease (GERD) is a common disorder associated with reflux of gastric contents through the gastroesophageal junction. There are ...
Veverimer Versus Placebo in Patients with Metabolic Acidosis Associated with Chronic Kidney Disease: a Multicenter, Randomized, Double-Blind, Controlled, Phase 3 ...
1. Among patients receiving laparoscopic antireflux surgery, 17.7% experienced recurrent GERD requiring medication or secondary antireflux surgery 2. Factors associated ...
Image: CC/S.Fruitsmaak 1. Distinguishing between physiologic gastroesophageal reflux (GER) and pathologic gastroesophageal reflux disease (GERD) is key to managing regurgitation ...
Feb 22nd - Magnetic sphincter augmentation was effective in reducing esophageal acid exposure and improved quality of life in gastric ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.